4 weeks Minimum interval between dose increases 2mg to 12mg Phase 2 dose range (Jastreboff 2023) ~12 weeks Time to reach 12mg on standard protocol 24.2% Weight loss at 12mg, 48 weeks (Phase 2) Investigational Drug Warning Retatrutide (LY3437943) is not FDA-approved as of April 2026
Inject Into Semaglutide: Insert the needle into the semaglutide vial and slowly release the water along the inner wall to avoid foaming
For millions of people who have been curious about GLP-1s but hesitant about injections, this moment feels like science just removed a very sharp needle from the equation
Full list of ingredients:Water, Glycerin, Propanediol, Dipropylene Glycol, Dipotassium Glycyrrhizate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Polyglyceryl-10 Laurate, Tromethamine, Allantoin, Sodium Polyacrylate, Eclipta Prostrata Extract, Coccinia Indica Fruit Extract, 1,2-Hexanediol, Glutathione (100Ppm), Hydroxyacetophenone, Caprylyl Glycol, Ethylhexylglycerin, Tocopherol, Disodium EDTA, Rosmarinus Officinalis (Rosemary) Leaf Oil
Makes me wonder whether it is a fake one or not, given that I ordered from Amazon
April 21, 2026